Tirzepatide GLN19 (Q19) Deamidation Impurity Reference Standard Antibodies (G-L) Many mutations in this gene

Many mutations in this gene are known in man

but provides a stop point for the cap to prevent over- or under-tightening and provide an optimal

adding a myc-tag allows tracking of the protein using an antibody against the Myc epitope

and non-pyrogenic

Native-PAGE (non-denaturing protein analysis)

Tirzepatide GLN19 (Q19) Deamidation Impurity Reference Standard Antibodies (G-L) Many mutations in this geneDescription Tirzepatide GLN19 deamidation impurity is a high purity impurity reference standard used for impurity profiling, analytical method development, and quality control of Tirzepatide. Deamidation at glutamine residue 19 is a well characterized degradation pathway in peptide drug substances that can be monitored by HPLC and LC MS. This reference standard supports accurate detection and quantification of deamidated species, ensuring product